Soluble urokinase plasminogen activator receptor (SuPAR) in patients with plasma cell dyscrasias, a pilot study

被引：0
|
作者：
Sudhini, Yashwanth [1 ]
Dhakal, Binod [2 ]
Reiser, Jochen [1 ]
Altintas, Mehmet [1 ]
Hahm, Eunsil [1 ]
Peev, Vasil [1 ]
Venugopal, Parameswaran [1 ]
Paner, Agne [1 ]
机构：
[1] Rush Univ, Med Ctr, Chicago, IL 60612 USA
[2] Med Coll Wisconsin, Milwaukee, WI 53226 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-441
引用
收藏
页码：S283 / S284
页数：2
相关论文
共 50 条
  • [21] Soluble urokinase Plasminogen Activator Receptor (suPAR) serum levels are elevated in patients with neuroendocrine neoplasia
    Burcin, Oe
    Mohr, R.
    Jann, H.
    Geisler, L.
    Tacke, F.
    Wiedenmann, B.
    Roderburg, C.
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 96 - 96
  • [22] Soluble urokinase-type plasminogen activator receptor (SuPAR) in patients with Parkinson's disease
    Witek, N.
    Joyce, J.
    Hawkins, J.
    Liu, Y.
    Ouyang, B.
    Patel, R.
    Borgia, J.
    Reiser, J.
    Hall, D.
    MOVEMENT DISORDERS, 2021, 36 : S460 - S460
  • [23] Soluble urokinase plasminogen activator receptor (suPAR) is associatedwith COPD readmission and mortality
    Hakansson, Kjell Erik Julius
    Ulrik, Charlotte Suppli
    Godtfredsen, Nina Skavlan
    Kallemose, Thomas
    Andersen, Ove
    Eugen-Olsen, Jesper
    Marsaa, Kristoffer
    Rasmussen, Line J. H.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [24] Soluble urokinase activator receptor (suPAR) in stem cell mobilization
    Sloand, EM
    BLOOD, 2005, 105 (05) : 1847 - 1848
  • [25] The prognostic value of plasma soluble urokinase plasminogen activator receptor (suPAR) levels in stage III ovarian cancer patients
    Begum, FD
    Hogdall, CK
    Kjaer, SK
    Christensen, L
    Blaakaer, J
    Bock, JE
    Glud, E
    Hoyer-Hansen, G
    Ring-Larsen, H
    Hogdall, EVS
    ANTICANCER RESEARCH, 2004, 24 (3B) : 1981 - 1985
  • [26] Increased Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels in Plasma of Suicide Attempters
    Ventorp, Filip
    Gustafsson, Anna
    Traskman-Bendz, Lil
    Westrin, Asa
    Ljunggren, Lennart
    PLOS ONE, 2015, 10 (10):
  • [27] Plasma levels of soluble urokinase plasminogen activator receptor (suPAR) as a possible biomarker for lung cancer and/or COPD
    Loukeri, Angeliki
    Spithakis, Panagiotis-Dimitrios
    Moschos, Charalampos
    Loukeri, Pinelopi
    Bartzeliotou, Anastasia
    Tzagkaraki, Aikaterini
    Stratos, Eustratios
    Veldekis, Dimitrios
    Kampolis, Christos F.
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [28] Soluble urokinase plasminogen activator receptor (suPAR) is an independent risk factor for stroke in patients with atrial fibrillation
    Westin, O.
    Rasmussen, L. J. H.
    Andersen, O.
    Eugen-Olsen, J.
    Friberg, J.
    EUROPEAN HEART JOURNAL, 2018, 39 : 406 - 406
  • [29] The role of the soluble urokinase plasminogen activator (suPAR) in children with pneumonia
    Wrotek, A.
    Jackowska, T.
    RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2015, 209 : 120 - 123
  • [30] Soluble urokinase plasminogen activator receptor (suPAR) in the assessment of inflammatory activity of rheumatoid arthritis patients in remission
    Toldi, Gergely
    Beko, Gabriella
    Kadar, Gabriella
    Macsai, Emilia
    Kovacs, Laszlo
    Vasarhelyi, Barna
    Balog, Attila
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2013, 51 (02) : 327 - 332
12345